- Home
- USAS vs THRD Comparison
USAS vs THRD Comparison
Compare USAS & THRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAS
- THRD
- Stock Information
- Founded
- USAS 1998
- THRD 2019
- Country
- USAS Canada
- THRD United States
- Employees
- USAS N/A
- THRD N/A
- Industry
- USAS Metal Mining
- THRD Biotechnology: Pharmaceutical Preparations
- Sector
- USAS Basic Materials
- THRD Health Care
- Exchange
- USAS Nasdaq
- THRD Nasdaq
- Market Cap
- USAS 285.0M
- THRD 335.2M
- IPO Year
- USAS N/A
- THRD 2022
- Fundamental
- Price
- USAS $0.53
- THRD $3.47
- Analyst Decision
- USAS Strong Buy
- THRD Buy
- Analyst Count
- USAS 1
- THRD 3
- Target Price
- USAS $0.80
- THRD $14.00
- AVG Volume (30 Days)
- USAS 1.3M
- THRD 1.2M
- Earning Date
- USAS 03-27-2025
- THRD 03-25-2025
- Dividend Yield
- USAS N/A
- THRD N/A
- EPS Growth
- USAS N/A
- THRD N/A
- EPS
- USAS N/A
- THRD N/A
- Revenue
- USAS $97,123,000.00
- THRD N/A
- Revenue This Year
- USAS $21.84
- THRD N/A
- Revenue Next Year
- USAS $46.00
- THRD N/A
- P/E Ratio
- USAS N/A
- THRD N/A
- Revenue Growth
- USAS 14.33
- THRD N/A
- 52 Week Low
- USAS $0.20
- THRD $3.18
- 52 Week High
- USAS $0.60
- THRD $16.94
- Technical
- Relative Strength Index (RSI)
- USAS 51.44
- THRD 25.71
- Support Level
- USAS $0.53
- THRD $3.18
- Resistance Level
- USAS $0.59
- THRD $3.70
- Average True Range (ATR)
- USAS 0.04
- THRD 0.31
- MACD
- USAS -0.00
- THRD 0.10
- Stochastic Oscillator
- USAS 37.75
- THRD 13.26
About USAS Americas Gold and Silver Corporation no par value
Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets are The Cosala operations, The Galena Complex, and Relief Canyon. The company also holds interests in the San Felipe Development Project located in Sonora, Mexico. It has geographic focus is the Western Hemisphere, particularly the United States and Mexico.
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.